Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aducanumab—Hope or Disappointment for Alzheimer’s Disease
Karolina Wojtunik‐Kulesza, Monika Rudkowska, Anna Orzeł-Sajdłowska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4367-4367
Open Access | Times Cited: 44

Showing 26-50 of 44 citing articles:

Elaboration of the Effective Multi-Target Therapeutic Platform for the Treatment of Alzheimer’s Disease Based on Novel Monoterpene-Derived Hydroxamic Acids
Yulia Aleksandrova, Aldar A. Munkuev, Evgenii S. Mozhaitsev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9743-9743
Open Access | Times Cited: 5
Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly
Deborah K. Sokol, Debomoy K. Lahiri
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
The performance of plasma phosphorylated tau231 in detecting Alzheimer's disease: A systematic review with meta‐analysis
Chang Xu, Li Zhao, Chunbo Dong
European Journal of Neuroscience (2023) Vol. 58, Iss. 4, pp. 3132-3149
Closed Access | Times Cited: 4
The Catastrophe of Intracerebral Hemorrhage Drives the Capillary-Hemorrhage Dementias, Including Alzheimer’s Disease
Jonathan Stone, John Mitrofanis, Daniel M. Johnstone, et al.
Journal of Alzheimer s Disease (2024) Vol. 97, Iss. 3, pp. 1069-1081
Closed Access | Times Cited: 1
Inhibitors of Soluble Epoxide Hydrolase and cGAS-STING Pathway Repair the Defects in Macrophage Clearance of Amyloid-β Underlying Vascular Complications of Alzheimer’s Disease Patients
Milan Fiala, Bruce D. Hammock, Sung‐Hee Hwang, et al.
(2024)
Open Access | Times Cited: 1
Novel pyrrolidine-alkylamino-substituted dicyanoisophorone derivatives as near-infrared fluorescence probe for imaging β-amyloid in vitro and in vivo
Hui Zhou, Jihang Zhai, Huiyuan Gong, et al.
Analytica Chimica Acta (2024) Vol. 1317, pp. 342894-342894
Closed Access | Times Cited: 1
Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
Madeline M. Vroom, Jean‐Cosme Dodart
Vaccines (2024) Vol. 12, Iss. 9, pp. 973-973
Open Access | Times Cited: 1
Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals
Selin Akpinar Adscheid, Akif Emre Türeli, Nazende Günday-Türeli, et al.
Beilstein Journal of Nanotechnology (2024) Vol. 15, pp. 1400-1414
Open Access | Times Cited: 1
Andrographolide derivative Andro-III modulates neuroinflammation and attenuates neuropathological changes of Alzheimer's disease via GSK-3β/NF-κB/CREB pathway
Min Hu, Miao Zheng, Can Wang, et al.
European Journal of Pharmacology (2023) Vol. 965, pp. 176305-176305
Closed Access | Times Cited: 3
Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation
Qingqing Zhou, Jiaxin Cai, Feixia Qin, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 97, pp. 117542-117542
Open Access | Times Cited: 2
A Potent Sybody Selectively Inhibits α-Synuclein Amyloid Formation by Binding to the P1 Region
Dimitra Gialama, Devkee M. Vadukul, Rebecca J. Thrush, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 12, pp. 9857-9868
Open Access
ACOT7, a candidate and novel serum biomarker of Alzheimer’s disease
Jintao Wang, Yong Feng, Yingni Sun
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access
Modern pharmacotherapy of Alzheimer's disease
Iva Holmerová, Martina Nováková
Klinická farmakologie a farmacie (2024) Vol. 38, Iss. 2, pp. 55-59
Open Access
Revisiting capsaicin and nonivamide: Their analogs exert strong inhibitory activity against cholinesterases
Niels V. Heise, Jeremy Quast, René Csük
European Journal of Medicinal Chemistry Reports (2024) Vol. 12, pp. 100200-100200
Open Access
Administration of Aripiprazole Alleviates Memory Impairment and Restores Damaged Glutamatergic System in 5xFAD Mice
Hae‐June Lee, Hyun‐Yong Kim, Se Jong Oh, et al.
Molecular Imaging and Biology (2024) Vol. 26, Iss. 5, pp. 879-887
Closed Access
Intranasal Lithium Chloride Nanoparticles Inhibit Inflammatory Pyroptosis in Brains and Ameliorate Memory Loss and Depression Behavior in 5xFAD mice
Piplu Bhuiyan, Wenjia Zhang, Liang Ge, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Stationary distribution and extinction of a stochastic Alzheimer's disease model
Ruoyun Lang, Yuanshun Tan, Yu Mu
AIMS Mathematics (2023) Vol. 8, Iss. 10, pp. 23313-23335
Open Access | Times Cited: 1
Molecular Mechanisms of Dementia
Mariagiovanna Cantone
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13027-13027
Open Access | Times Cited: 1
Advancing Alzheimer’s care: a novel therapy with lecanemab
Advait Teli, Priti Dhande
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2023) Vol. 59, Iss. 1
Open Access | Times Cited: 1
Previous Page - Page 2

Scroll to top